$11 MILLION DOLLARS IN DONATIONS. 100% OF THE FUNDS GO TO GIST CANCER RESEARCH!Since its inception in 2001, the GIST Cancer Research Fund has been relentless to find a cure for GIST Cancer. To date, we have reached $11 million dollars. The most important part of the achievement is that 100% of all the funds raised went to GIST Cancer Research. Brian Druker, M.D., Director, OHSU Knight Cancer Institute and a GCRF advisor, revolutionized the treatment of cancer through research that resulted in Gleevec®, the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed.
TEAM TURANO ANNOUNCES 2021 ANNUAL GCRF FUNDRAISERThe Turano Family announced that the 2021 Annual GIST Cancer Research Fundraiser will be held on September 17, 2021 in New Jersey. Stay tuned for more details. The Turanos have raised much needed funds for GIST Cancer Research. Their tireless efforts have raised close to $100,000 for GIST Cancer Research.
NEXT YEAR'S NY WALK FOR A CURE • SEPTEMBER 19, 2021 • JOIN US FOR OUR 20TH ANNIVERSARY!
VIRTUAL WALKS A SUCCESS
New York: $46,000 +
San Jose: $20,000.+
$66,000. and still growing
There is still time to set up your own Walk. Donations are still being accepted!
Mail checks to:
GIST Cancer Research Fund
3905 N.E. 167th Street
North Miami Beach, Florida 33160
Ms. Liz Chew
1630 Coraltree Place
San Jose, California 95131
“Thank you to Tania, Robert and everyone with the GIST Cancer Research Fund for your loyal support of the OHSU Knight Cancer Institute in our mission to end cancer as we know it. I am inspired and humbled by your commitment to us. Thank you again.”
Brian Druker, M.D., Director, OHSU Knight Cancer Institute
Dr. Anette U. Duensing, MD, GIST Cancer Researcher at the University of Pittsburgh Cancer Institute, Reports On Latest Research
Dr. Anette Duensing, GCRF's advisor, Associate Professor of Pathology and member of the Cancer Therapeutics Program at the University of Pittsburgh Cancer Institute gives an update on her latest research on GIST Cancer.
Dr. Meg von Mehren & Fox Chase Cancer Team Report
Dr. Meg von Mehren, GCRF's GIST Cancer Advisor and researcher at The Fox Chase Cancer Center, Philadelphia, PA, gives an update on how GCRF has helped their research.
Dr. Cristina R. Antonescu and Dr. Ping Chi's GIST Research Update 2020
Watch the presentation by Dr. Cristina R. Antonescu and Dr. Ping Chi on their ongoing, joint research for GIST Cancer at Memorial Sloan Kettering Cancer Center for 2020.
FDA Approval Of AYVAKIT™ (Avapritinib), The First Approved Precision Therapy For GIST
The FDA granted a full approval to AYVAKIT™ (avapritinib) based on efficacy results from the Phase 1 NAVIGATOR clinical trial, as well as combined safety results from multiple clinical trials for avapritinib. Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy announced that AYVAKIT™ (avapritinib) is used for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations. AYVAKIT is the first precision therapy approved to treat a genomically defined population of patients with GIST. Blueprint Medicines plans to make AYVAKIT available in the U.S. within a week.
For more detailed information on AYVAKIT™ (avapritinib), click on the following link:
FDA Approval AYVAKIT™
Keep Giving To Find A Cure. Donate Now!
Tania Stutman, Chairperson
Robert Stutman, Director, Treasurer
Pamela Fedowich, Director
Wendy Kapiloff, Director
Mark Landesman, Director
Bruce Torrey, Director
Karen Turano, Director
Angelo Turano, Director
William Price, Director, Posthumous Emeritus
GIST 2019 NY Walk For A Cure
The 2019 GCRF Walk For A Cure in New York was held on September 22, 2019 at Rockland Lake State Park. Thanks to all who attended and helped to save lives.
GIST - A Rare Orphan Cancer
Gastrointestinal Stromal Tumor or GIST is a rare, orphan cancer which starts in a type of tissue called the stromal or the body’s connective tissue (fat, muscle, blood vessels, deep skin tissues, nerves, bones or cartilage). GIST is a silent cancer often spreading before the patient has symptoms. Each year, approximately 5,000 adults in the United States alone are diagnosed with GIST Cancer. According to the American Cancer Society, many doctors misdiagnose GIST as another type of GI cancer. The lifesaving treatment for GIST is delayed and the GIST Cancer destroys lives. The overall five year survival rate of people diagnosed with a malignant tumor has been estimated to be 76%.
Looking For A GIST Cancer Doctor?
GIST is a rare form of cancer that most doctors misdiagnose or are not familiar with the appropriate treatment. If you or a loved-one is diagnosed with GIST, getting in touch with a physician who specializes in GIST Cancer is of utmost importance. These doctors and researchers deal with this disease on a daily basis and can help guide you to the right treatment.
In addition to the GIST Cancer Research Team of physicians, researchers and nurses, the following link will put you in touch with domestic and international GIST Cancer specialists.
Memorial Sloan Kettering Cancer Center Honors The GCRF On Its Donor Wall in New York City
In 2012, The GIST Cancer Research Fund and Robert and Tania Stutman were honored by Memorial Sloan Kettering Cancer Center for GCRF’s generous donations given for GIST Cancer Research. Their names were etched into MSKCC’s donor wall for posterity. For almost twenty years, The GIST Cancer Research Fund has been tirelessly fighting to raise funds to eradicate this deadly disease with no staff, corporate headquarters or overhead. Since 2002, the foundation has raised more than $10 million and MSK has been the beneficiary of $1.6 million. Events including walkathons, 1,000-mile Cycling for a Cure bike rides, golf outings and galas now span the nation. (Other GCRF beneficiaries include Fox Chase, Brigham and Women’s Hospital in Boston, Oregon Health Sciences University Cancer Institute, and MD Anderson Cancer Center in Houston.) At MSK, the GCRF supports the work of Dr. Antonescu and Dr. Ping Chi.
Robert and Tania Stutman join the generous philantropists including Susan G. Komen, who donate to MSKCC. The GCRF has raised $10 million dollars for GIST Cancer Research and has given 100% of these fund to finding a cure for GIST Cancer. As Tania Stutman said, ‘I’m not only battling for my life, I’m fighting for the lives of others.’”
Tania’s Story and the Formation of the GIST Cancer Research Fund
“I started with just a little website,” Tania says. “I went on local radio. I went to our local paper and told them my story.” In 2001, she held her first walkathon and raised $23,000. In 2018, the foundation has raised more than $10 million dollars and every penny has gone to GIST Cancer Research.
United States Senator, Charles “Chuck” Schumer graciously acknowledged the GIST Cancer Research Fund with a proclamation for the importance of the numerous contributions that the GIST Cancer Research Fund and the Walk For A Cure has made to find a cure for GIST Cancer.
Thank You Dr. Mike Heinrich and the Heinrich Lab For Walking For A Cure In Portland, Oregon
The GCRF is a GIST patient-run non-profit (501(c)(3)) that has supported the GIST basic research being performed in the laboratory of Dr. Michael Heinrich* here at OHSU, as well as numerous other GIST research programs around the United States, for nearly two decades. The funds donated to research from the GCRF fund research for improving the care of GIST patients. Without the support of the GCRF, the immense progress that has been made in improving GIST patient care at OHSU would not have been possible.
*Dr. Mike Heindrick has pledged to match all donations made from our participants.*
Be generous and click on the button below to donate today!
Dr. Michael Heindrick's GIST Research Update 2020
Dr. Michael C. Heinrich, one of GCRF's GIST Cancer Advisors and researcher at The OHSU Knight Cancer Institute in Portland, Oregon, gives an update of his work and progress of finding a cure for GIST.
Dr. Ron DeMatteo Starts The 2020 Virtual Walk!
GCRF's own GIST Cancer advisor, Dr. Ron DeMatteo, of Penn Medicine in Philadelphia, Pennsylvania, begins the 2020 GCRF Virtual Walk For A Cure. He is the Chairman of the Department of Surgery and a Surgical Oncologist who specializes in treating abdominal sarcomas (GIST) and diseases of the liver, bile duct, gallbladder and pancreas. We are so grateful to have his support in the cure for GIST Cancer.
Other GSRF Walkers include GCRF Board Member, Wendy Kapiloff and family in memory of her husband, Lenny Kapiloff.
The OHSU Knight Cancer Institute’s 2019 GIST Education Conference & Luncheon
The OHSU Knight Cancer Institute & the GIST Cancer Research Fund held a one‐day education conference on May 7 in Portland, Oregon. The conference highlighted the advancements in Gastrointestinal Stromal Tumors (GIST) Research. Among the presenters was OHSU’s Dr. Brian Druker, developer of the drug Gleevec, Dr. Chris Corless and Dr. Michael Heinrich. A special presentation was given by Dr. Brian Druker to celebrate Tania Stuntman’s 70th birthday. After 21 years since she received her GIST Cancer diagnosis, she is still fighting and keeping hope alive.
Walt "Clyde" Frazier, GCRF's Distinguished Spokesperson
Walt Frazier is a two-time NBA champion with the New York Knicks, a seven-time NBA All-Star and a member of the Basketball Hall of Fame. His retired No. 10 Knicks jersey is hanging in the rafters in Madison Square Garden. The NBA veteran is also known to be the GCRF's very own spokesperson. Walt has attended the GCRF New York Walk For A Cure for 18 years. His loyalty and commitment to GIST Cancer Research is relentless and he always finds the time to "be there" for the GIST Cancer Research Fund in good times and bad. Thank you Walt for all you have done and know that we hold a special place for you in our hearts!
Welcome to the Heinrich-Corless Research Lab
A look behind the scenes in the lab of Dr. Michael Heinrich and Dr. Chris Corless at the Oregon Health & Science Center/Knight Cancer Institute. Here is an overview of the current research being performed to find a cure for GIST Cancer.
Dr. Jonathan Fletcher Emphasizes Enormous Impact that GCRF has on GIST Cancer Research
Dr. Jonathan Fletcher (The Fletcher Laboratory at Brigham And Women's Hospital) emphasized the GIST Cancer Research Fund's added value of supporting GIST research. Not only that all the support flows to the research labs, but also that each gift supports important research right now ... while also enabling talented young physician-scientists to establish careers in GIST research. In that sense, all donations are truly gifts that keep on giving and have a very high impact on development of new GIST therapies.
Save Lives And Show Your Feelings About GIST Cancer
GCRF has GIST Cancer Bracelets, Ribbons and T-Shirts available for sale. By wearing and displaying them, you are spreading a message and awareness to find a cure for this rare cancer.
Donate today to spread awareness and find a cure! To Purchase, Click On The Button Below.
AmazonSmile is a simple and automatic way for you to support the Gist Cancer Research Fund every time you shop, at no cost to you. When you shop at smile.amazon.com, The AmazonSmile Foundation will donate 0.5% of the purchase price from your eligible AmazonSmile purchases. Please support GCRF when you shop on Amazon! Click on the amazon smile logo for more information.
IN MEMORY OF
January 14, 1957 - February 19, 2018
HONOR MY LIFE BY LIVING YOURS!
Special Thanks To Our 2019 GCRF San Jose Walk For A Cure Sponsor
Elisabeth Andreason, Executive Director of The Andreason Group at Morgan Stanley, a financial advising and investing group located in Walnut Creek, California, generously donated $5,000 to the 2019 San Jose Walk For A Cure. 100% of this donation will go directly to the GIST Cancer Doctors and Research labs to keep hope alive to find a cure. Thank you very much Elizabeth and Morgan Stanley!